{"date":"2026-05-08","count":67,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-8403-2026-05-08-2200-8h2rj2","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"22:00:44","subject":"公告本公司董事會決議召開115年股東常會(新增討論事項)","clause":"第17款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-05-08 22:00，「公告本公司董事會決議召開115年股東常會(新增討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2026-05-08-2135-92x690","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"21:35:52","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-05-08 21:35，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-05-08-1951-9h0ctm","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"19:51:16","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-05-08 19:51，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-05-08-1856-1na5ty6","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"18:56:50","subject":"本公司115年第1季合併財務報告已提報董事會","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-05-08 18:56，「本公司115年第1季合併財務報告已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-05-08-1851-92x690","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"18:51:54","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-05-08 18:51，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-05-08-1850-1dzhaae","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"18:50:34","subject":"公告本公司董事會決議召開2026年股東常會事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-05-08 18:50，「公告本公司董事會決議召開2026年股東常會事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-05-08-1848-sdisny","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"18:48:41","subject":"公告本公司董事會通過115年度第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-05-08 18:48，「公告本公司董事會通過115年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-05-08-1847-qf4qhx","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"18:47:25","subject":"公告本公司提報董事會2026年第1季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-05-08 18:47，「公告本公司提報董事會2026年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2026-05-08-1840-7qz6ea","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"18:40:08","subject":"公告本公司115年第1季合併財務報告業經提報董事會通過","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-05-08 18:40，「公告本公司115年第1季合併財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-08-1829-9h0ctm","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"18:29:05","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-08 18:29，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-08-1827-1egfkms","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"18:27:54","subject":"公告本公司董事會通過重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-08 18:27，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-05-08-1753-fx4poh","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-08","time":"17:53:09","subject":"公告本公司董事會決議召開115年股東會常會相關事宜(增列召集事由)","clause":"第32款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-05-08 17:53，「公告本公司董事會決議召開115年股東會常會相關事宜(增列召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-05-08-1747-1x4fuk3","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-08","time":"17:47:22","subject":"公告本公司董事會決議通過新設立美國子公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-05-08 17:47，「公告本公司董事會決議通過新設立美國子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-05-08-1746-ygkpln","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-08","time":"17:46:47","subject":"公告本公司董事會通過副總經理任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-05-08 17:46，「公告本公司董事會通過副總經理任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-05-08-1729-9h0ctm","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"17:29:13","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-05-08 17:29，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-05-08-1722-14apxzx","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-05-08","time":"17:22:57","subject":"公告本公司董事會通過115年股東常會相關事宜。(新增股東會討論議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-05-08 17:22，「公告本公司董事會通過115年股東常會相關事宜。(新增股東會討論議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-05-08-1717-jb55yw","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"17:17:08","subject":"公告本公司董事會通過重要決議事項","clause":"第53款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-05-08 17:17，「公告本公司董事會通過重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-05-08-1716-16febev","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"17:16:11","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-05-08 17:16，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-05-08-1703-16febev","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"17:03:39","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-05-08 17:03，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-05-08-1701-1fi4rwp","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"17:01:25","subject":"公告本公司董事會決議召開115年股東常會事宜(新增討論事項)","clause":"第17款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-05-08 17:01，「公告本公司董事會決議召開115年股東常會事宜(新增討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-05-08-1659-9xt462","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:59:30","subject":"公告本公司董事會決議對子公司益興生醫股份有限公司增加投資","clause":"第20款","fact_date":"2026-08-08","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-05-08 16:59，「公告本公司董事會決議對子公司益興生醫股份有限公司增加投資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-05-08-1659-ytlh5e","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"16:59:15","subject":"公告本公司董事會決議召開一一五年股東常會事宜(新增討論事項)","clause":"第17款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-05-08 16:59，「公告本公司董事會決議召開一一五年股東常會事宜(新增討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-05-08-1656-7lvi8z","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:56:03","subject":"本公司會計主管異動","clause":"第8款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-05-08 16:56，「本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-05-08-1655-1qchk12","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:55:33","subject":"公告邦特生物科技(股)公司配發現金股利相關事宜","clause":"第14款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-05-08 16:55，「公告邦特生物科技(股)公司配發現金股利相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-05-08-1653-1ab1kcu","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:53:51","subject":"公告本公司民國115年度第1季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-05-08 16:53，「公告本公司民國115年度第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-05-08-1650-ntu6lr","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-05-08","time":"16:50:48","subject":"公告本公司董事會決議買回庫藏股事宜。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-05-08 16:50，「公告本公司董事會決議買回庫藏股事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-05-08-1638-1xo4yva","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:38:52","subject":"公告本公司115年第一季合併財務報告業經董事會決議通過","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-05-08 16:38，「公告本公司115年第一季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-05-08-1633-1kzq46c","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:33:26","subject":"公告本公司董事會決議不繼續辦理114年股東常會通過之私募普通股案","clause":"第16款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-05-08 16:33，「公告本公司董事會決議不繼續辦理114年股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-05-08-1628-vdzgwf","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-05-08","time":"16:28:49","subject":"公告本公司高肝腎安全性乙醯胺酚止痛新藥SNP-810(安泰拿疼)除已獲准美國、歐洲、中國、日本、韓國等54國專利外，再取得日本專利","clause":"第44款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-05-08 16:28，「公告本公司高肝腎安全性乙醯胺酚止痛新藥SNP-810(安泰拿疼)除已獲准美國、歐洲、中國、日本、韓國等54國專利外，再取」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-05-08-1622-1pojjj2","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:22:40","subject":"公告本公司115年第1季合併財務報告經董事會決議通過","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-05-08 16:22，「公告本公司115年第1季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-05-08-1613-tzaprt","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:13:51","subject":"公告本公司董事會決議買回本公司股份並辦理轉讓員工","clause":"第35款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-05-08 16:13，「公告本公司董事會決議買回本公司股份並辦理轉讓員工」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-08-1606-1mwjljt","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"16:06:16","subject":"公告本公司董事會通過115年第一季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-08 16:06，「公告本公司董事會通過115年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-05-08-1603-nlh9os","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:03:25","subject":"本公司國內第一次無擔保轉換公司債(強生一)到期還本及終止上櫃日期公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-05-08 16:03，「本公司國內第一次無擔保轉換公司債(強生一)到期還本及終止上櫃日期公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-05-08-1600-qn4bze","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"16:00:31","subject":"本公司董事會決議通過本公司115年度第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-05-08 16:00，「本公司董事會決議通過本公司115年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-08-1554-x1p1f9","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:54:35","subject":"公告本公司庫藏股買回數量累積達已發行股份總數百分之四","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-08 15:54，「公告本公司庫藏股買回數量累積達已發行股份總數百分之四」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2026-05-08-1546-1hw9n7o","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:46:10","subject":"公告本公司董事會通過115年度第1季財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：進階（3118），2026-05-08 15:46，「公告本公司董事會通過115年度第1季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-05-08-1542-jm5co5","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:42:28","subject":"公告本公司董事會通過115年度第一季財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-05-08 15:42，「公告本公司董事會通過115年度第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-05-08-1538-54swv6","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-05-08","time":"15:38:38","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-05-08 15:38，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-05-08-1538-58zfmu","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:38:37","subject":"公告本公司總經理異動案","clause":"第6款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-05-08 15:38，「公告本公司總經理異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-05-08-1538-1mf3dmr","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:38:00","subject":"公告本公司董事會決議115年第1季股利發放","clause":"第14款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-05-08 15:38，「公告本公司董事會決議115年第1季股利發放」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-05-08-1537-4vh25b","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:37:35","subject":"公告本公司董事會通過民國115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-05-08 15:37，「公告本公司董事會通過民國115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-05-08-1535-16k2ui6","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"15:35:10","subject":"公告本公司庫藏股轉讓員工之認股基準日","clause":"第51款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-05-08 15:35，「公告本公司庫藏股轉讓員工之認股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-05-08-1534-ykuco7","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"15:34:41","subject":"本公司董事會決議通過子公司PEGAVISION VIETNAM COMPANY LIMITED租地委建宿舍工程","clause":"第20款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-05-08 15:34，「本公司董事會決議通過子公司PEGAVISION VIETNAM COMPANY LIMITED租地委建宿舍工程」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-05-08-1534-14msre1","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"15:34:09","subject":"公告本公司董事會決議買回庫藏股(修訂「第一次買回股份轉讓員工辦法」)","clause":"第35款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-05-08 15:34，「公告本公司董事會決議買回庫藏股(修訂「第一次買回股份轉讓員工辦法」)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-05-08-1533-1oqziqy","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"15:33:37","subject":"公告本公司經理人晉升案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-05-08 15:33，「公告本公司經理人晉升案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-05-08-1533-11m9buf","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"15:33:10","subject":"公告本公司於董事會通過民國一一五年度第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-05-08 15:33，「公告本公司於董事會通過民國一一五年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-05-08-1530-sdisny","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"15:30:36","subject":"公告本公司董事會通過115年度第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-05-08 15:30，「公告本公司董事會通過115年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-05-08-1528-16febev","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"15:28:26","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-05-08 15:28，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-05-08-1524-90qcd6","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"15:24:31","subject":"本公司代重要子公司杏業生技(股)公司公告與聯貸銀行團簽訂聯合授信合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-05-08 15:24，「本公司代重要子公司杏業生技(股)公司公告與聯貸銀行團簽訂聯合授信合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-05-08-1520-puuep8","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:20:47","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告","clause":"第23款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-05-08 15:20，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-05-08-1518-1tha3a1","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:18:15","subject":"召開本公司115年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-05-08 15:18，「召開本公司115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-05-08-1516-1fv4mk1","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:16:18","subject":"本公司董事會決議114年以私募現金增資發行普通股(補充公告證券承銷商出具辦理私募必要性與合理性之評估意見)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-05-08 15:16，「本公司董事會決議114年以私募現金增資發行普通股(補充公告證券承銷商出具辦理私募必要性與合理性之評估意見)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-05-08-1515-1ll17cw","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:15:55","subject":"本公司董事會決議修訂以私募現金增資發行普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-05-08 15:15，「本公司董事會決議修訂以私募現金增資發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-05-08-1515-ee0bb1","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:15:00","subject":"本公司115年第一季合併財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-05-08 15:15，「本公司115年第一季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-05-08-1514-1e3qu3s","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:14:34","subject":"公告本公司董事會通過新任公司治理主管案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-05-08 15:14，「公告本公司董事會通過新任公司治理主管案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-05-08-1514-1euuce7","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"15:14:10","subject":"公告本公司董事會通過新任財務主管、會計主管案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-05-08 15:14，「公告本公司董事會通過新任財務主管、會計主管案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-05-08-1456-1tswu7a","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"14:56:39","subject":"公告本公司董事會追認修正「115年度員工認股權憑證發行及認股辦法」","clause":"第11款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-05-08 14:56，「公告本公司董事會追認修正「115年度員工認股權憑證發行及認股辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-05-08-1455-9h0ctm","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"14:55:35","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-05-08 14:55，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-05-08-1454-9h0ctm","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"14:54:29","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-05-08 14:54，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-05-08-1433-16febev","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"14:33:25","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-05-08 14:33，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-05-08-1424-9h0ctm","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"14:24:44","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-05-08 14:24，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-05-08-1423-1mwjljt","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-05-08","time":"14:23:48","subject":"公告本公司董事會通過115年第一季財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-05-08 14:23，「公告本公司董事會通過115年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2026-05-08-1419-fcjkc2","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"14:19:50","subject":"公告本公司經董事會決議之115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2026-05-08 14:19，「公告本公司經董事會決議之115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-05-08-1416-isqttc","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"14:16:44","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-05-08 14:16，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-05-08-1415-9h0ctm","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"14:15:25","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-05-08 14:15，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-05-08-1409-1rqnwni","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-05-08","time":"14:09:11","subject":"本公司受邀參加富邦綜合證券舉辦之法人說明會。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-05-08 14:09，「本公司受邀參加富邦綜合證券舉辦之法人說明會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-05-08-1354-s364tb","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-05-08","time":"13:54:22","subject":"公告本公司訂定除息基準日","clause":"第14款","fact_date":"2026-05-08","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-05-08 13:54，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}